Tag: biotech acquisition
Eli Lilly Acquires AtaiBeckley to Accelerate Innovative Depression Treatments
Eli Lilly and Company and AtaiBeckley Inc. announced a agreement for Lilly to acquire AtaiBeckley. The transaction features cash consideration of $6.75 per share,...
GSK Launches Tender Offer to Acquire Precision Oncology Innovator Nuvalent, Inc.at $124.00
GSK plc has officially commenced a tender offer to acquire all issued and outstanding shares of Class A and Class B common stock of Nuvalent,...
Johnson & Johnson to acquire Firefly Bio to advance novel cancer treatment
Johnson & Johnson announced that it has entered into a definitive agreement to acquire Firefly Bio, Inc., a privately held biotechnology company specializing in...